G. Bernhard Landwehrmeyer

Best Publications

• Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values

  R. Rolke;R. Baron;C. Maier;T.R. Tölle

  2858
  Citations

• Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes

  C. Maier;R. Baron;T. R. Tölle;A. Binder

  1283
  Citations

• Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

  Sarah J Tabrizi;Douglas R Langbehn;Blair R Leavitt;Raymund A C Roos

  1076
  Citations

• Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data

  Sarah J Tabrizi;Rachael I Scahill;Gail N Owen;Alexandra Durr

  956
  Citations

• Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis

  Sarah J Tabrizi;Rachael I Scahill;Alexandra Durr;Raymund A C Roos

  686
  Citations

• Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

  Wouter van Rheenen;Aleksey Shatunov;Annelot M. Dekker;Russell L. McLaughlin

  646
  Citations

• Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease

  Jong-Min Lee;Vanessa C. Wheeler;Michael J. Chao;Jean Paul G. Vonsattel

  622
  Citations

• Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data

  Sarah J Tabrizi;Ralph Reilmann;Raymond A C Roos;Alexandra Durr

  602
  Citations

• A Protein Interaction Network Links GIT1, an Enhancer of Huntingtin Aggregation, to Huntington’s Disease

  Heike Goehler;Maciej Lalowski;Ulrich Stelzl;Stephanie Waelter

  601
  Citations

• Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions.

  Astrid Lunkes;Katrin S. Lindenberg;Léa Ben-Haı̈em;Chantal Weber

  582
  Citations

• CAG repeat not polyglutamine length determines timing of Huntington’s disease onset

  Jong-Min Lee;Kevin Correia;Jacob Loupe;Kyung-Hee Kim

  513
  Citations

• NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum

  GB Landwehrmeyer;DG Standaert;CM Testa;JB Penney

  475
  Citations

• CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

  J.-M. Lee;E.M. Ramos;J.-H. Lee;T. Gillis

  449
  Citations

• Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain

  A.T. Bruinvels;B. Landwehrmeyer;E.L. Gustafson;M.M. Durkin

  427
  Citations

• Transgenic rat model of Huntington's disease

  Stephan von Hörsten;Ina Schmitt;Huu Phuc Nguyen;Carsten Holzmann

  410
  Citations

• Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.

  Edith L. Pfister;Lori A. Kennington;Juerg R. Straubhaar;Sujata Wagh

  373
  Citations

• Metabotropic glutamate receptors are differentially regulated during development

  M.V. Catania;G.B. Landwehrmeyer;C.M. Testa;D.G. Standaert

  363
  Citations

• Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy

  Richard G. Brown;Lucette Lacomblez;Bernard G. Landwehrmeyer;Thomas Bak

  354
  Citations

• Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

  Davina J Hensman Moss;Antonio F Pardiñas;Douglas Langbehn;Kitty Lo

  347
  Citations

• Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study

  J Kassubek;F D Juengling;T Kioschies;K Henkel

  329
  Citations